| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |